Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-05 Purchase | 2024-11-06 3:16 pm | BIODESIX INC | BDSX | Strobeck Matthew Director | 40,000 | $1.3979 | $55,916 | 5,666,484 (Indirect Direct) | View |
| 2023-03-23 Purchase(A) | 2024-02-20 12:27 pm | ELUTIA INC. | ELUT | Birchview Capital LP Birchview Fund LLC Strobeck Matthew 10% owner in previous filing | 140,000 | $1.4783 | $206,958 | 1,655,184 (Indirect) | View |
| 2024-01-23 Purchase | 2024-01-25 4:12 pm | Accelerate Diagnostics Inc | AXDX | Strobeck Matthew Director | 100,000 | $0 | $0 | 425,238 (Indirect Direct) | View |
| 2023-03-23 Purchase | 2023-03-27 4:17 pm | AZIYO BIOLOGICS INC. | AZYO | Birchview Capital LP Birchview Fund LLC Strobeck Matthew 10% Owner | 140,000 | $1.4783 | $206,958 | 1,655,184 (Indirect) | View |
| 2022-05-11 Purchase | 2023-02-13 7:01 pm | AZIYO BIOLOGICS INC. | AZYO | Birchview Capital LP Birchview Fund LLC Strobeck Matthew 10% Owner | 97,261 | $4.0944 | $398,230 | 1,515,184 (Indirect) | View |
| 2022-11-21 Purchase | 2022-11-21 6:02 pm | BIODESIX INC | BDSX | Strobeck Matthew Director | 2,669,562 | $1.15 | $3,069,996 | 4,610,825 (Indirect Direct) | View |
| 2022-04-07 Purchase | 2022-04-11 4:36 pm | BIODESIX INC | BDSX | Strobeck Matthew Director | 1,117,318 | $1.79 | $1,999,999 | 2,390,115 (Indirect Direct) | View |
| 2021-12-30 Purchase | 2022-01-04 5:02 pm | BIODESIX INC | BDSX | Strobeck Matthew Director | 147,800 | $4.35 | $642,930 | 1,041,553 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-24 Exercise | 2024-05-29 4:41 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 2,416 | $0 | 67,621 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 4:41 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 2,416 | $0 | 67,621 (Direct) | View |
| 2024-05-23 Exercise | 2024-05-23 7:15 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 356,536 | $0 | 5,721,260 (Indirect) | View |
| 2024-05-21 Option Award | 2024-05-23 7:15 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 90,776 | $0 | 5,721,260 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-23 6:29 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 4,929 | $0 | 4,929 (Direct) | View |
| 2024-04-05 Option Award | 2024-04-09 7:36 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 8,696 | $46 | 8,696 (Indirect) | View |
Ownership(A) | 2024-02-20 12:18 pm | N/A N/A | ELUTIA INC. | ELUT | Birchview Capital LP Birchview Fund LLC Strobeck Matthew 10% Owner in previous filing | 0 | $0 | 1,655,184 (Indirect) | View |
| 2024-01-01 Option Award | 2024-01-03 4:19 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 105,389 | $0 | 140,036 (Direct) | View |
| 2023-08-03 Option Award | 2023-08-07 5:33 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 288,270 | $1.62 | 2,617,106 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-29 5:55 pm | N/A N/A | Accelerate Diagnostics Inc | AXDX | Strobeck Matthew Director | 236,842 | $0 | 236,842 (Direct) | View |
| 2023-06-06 Exercise | 2023-06-08 4:31 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 2,248 | $0 | 65,205 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:31 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 2,248 | $0 | 65,205 (Direct) | View |
| 2023-05-29 Option Award | 2023-06-01 6:25 pm | N/A N/A | Accelerate Diagnostics Inc | AXDX | Strobeck Matthew Director | 78,947 | $0 | 78,947 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:22 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 2,416 | $0 | 2,416 (Direct) | View |
| 2023-05-23 Option Award | 2023-05-25 6:22 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 34,647 | $0 | 34,647 (Direct) | View |
| 2023-05-18 Exercise | 2023-05-22 4:08 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 512 | $0 | 62,957 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-22 4:08 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 512 | $0 | 62,957 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 6:21 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 1,137 | $0 | 62,445 (Direct) | View |
| 2023-05-14 Option Award | 2023-05-16 6:21 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 1,137 | $0 | 62,445 (Direct) | View |
Ownership | 2023-02-13 6:54 pm | N/A N/A | AZIYO BIOLOGICS INC. | AZYO | Birchview Capital LP Birchview Fund LLC Strobeck Matthew 10% Owner | 0 | $0 | 1,417,923 (Indirect) | View |
| 2023-01-03 Option Award | 2023-01-05 4:31 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 6,097 | $0 | 151,930 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 6:20 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 62,500 | $0 | 145,833 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 6:20 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 2,248 | $0 | 2,248 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:22 pm | N/A N/A | Accelerate Diagnostics Inc | AXDX | Strobeck Matthew Director | 75,949 | $0 | 75,949 (Direct) | View |
| 2022-05-27 Option Award | 2022-06-01 5:36 pm | N/A 2028-04-04 | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 63,216 | $0 | 46,586 (Direct) | View |
Ownership | 2022-06-01 4:57 pm | N/A N/A | QuidelOrtho Corp | QDEL | Strobeck Matthew Director | 0 | $0 | 0 (Direct) | View |
| 2022-05-27 Disposition | 2022-06-01 4:27 pm | N/A 2028-04-04 | QUIDEL CORP | QDEL | Strobeck Matthew Director | 63,216 | $0 | 0 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:16 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 83,333 | $0 | 83,333 (Direct) | View |
| 2022-05-18 Exercise | 2022-05-20 7:50 pm | 2022-05-18 2022-05-18 | QUIDEL CORP | QDEL | Strobeck Matthew Director | 1,624 | $0 | 61,308 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 4:15 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 20,044 | $0 | 1,272,797 (Direct) | View |
| 2021-09-30 Option Award | 2021-12-10 4:01 pm | N/A N/A | Accelerate Diagnostics Inc | AXDX | Strobeck Matthew Director | 19,531 | $7.68 | 2,252,388 (Indirect) | View |
| 2021-06-29 Option Award | 2021-07-01 6:26 pm | N/A N/A | BIODESIX INC | BDSX | Strobeck Matthew Director | 20,044 | $0 | 20,044 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 9:59 pm | N/A 2031-05-20 | Accelerate Diagnostics Inc | AXDX | Strobeck Matthew Director | 35,168 | $0 | 35,168 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-20 8:42 pm | N/A N/A | QUIDEL CORP | QDEL | Strobeck Matthew Director | 2,136 | $0 | 2,136 (Direct) | View |
| 2021-05-12 Exercise | 2021-05-14 8:15 pm | 2021-05-12 2021-05-12 | QUIDEL CORP | QDEL | Strobeck Matthew Director | 1,040 | $0 | 59,684 (Direct) | View |
| 2021-04-09 Option Award | 2021-04-13 4:21 pm | N/A N/A | Accelerate Diagnostics Inc | AXDX | Strobeck Matthew Director | 19,531 | $7.68 | 2,232,857 (Indirect) | View |
| 2021-02-19 Option Award | 2021-02-24 1:08 pm | N/A N/A | Accelerate Diagnostics Inc | AXDX | Strobeck Matthew Director | 19,531 | $7.68 | 2,213,326 (Indirect) | View |